Benzinga | Feb 8, 2021 09:36AM EST

Raymond James Maintains Strong Buy on Zimmer Biomet Holdings, Raises Price Target to $187

Raymond James analyst Lawrence Keusch maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Strong Buy and raises the price target from $170 to $187.